256
Participants
Start Date
January 31, 2011
Primary Completion Date
November 30, 2011
Study Completion Date
November 30, 2011
Delafloxacin
300mg IV every 12 hours for 5-14 days
Linezolid
600mg IV every 12 hours for 5-14 days
Vancomycin
15mg/kg, up to 1250 mg, IV every 12 hours for 5-14 days
Montefiore Medical Center, The Bronx
Christiana Care Health Services, Newark
Atlanta Institute for Medical Research, Inc, Decatur
Southeast Regional Research Group, Savannah
Southeast Regional Research Group, Columbus
Riverside Clinical Research, Edgewater
River City Clinical Research, Jacksonville
Central Florida Internists Medical, Orlando
Ronald Barbour, MD, Temple Terrace
Central Florida Internists, Kissimmee
Central Florida Internists, Saint Cloud
Drug Research and Analysis Corp, Montgomery
University of South Alabama Medical Center, Mobile
Four Rivers Clinical Research, Inc, Paducah
Remington-Davis, Inc., Columbus
Ravi Kamepalli, MD, Lima
Health Concepts, Rapid City
Mercury Street Medical Group, PLLC, Butte
University of Missouri Health Care, Columbia
University of Kansas Medical Center, Kansas City
Medical Development Centers, LLC, Baton Rouge
Jennifer Johnson-Caldwell, MD, Houston
Alan Nolasco, MD, Houston
eStudySite, Las Vegas
HealthCare Partners Medical Group, Los Angeles
Southbay Pharma Research, Buena Park
HealthCare Partners Medical Group, Pasadena
eStudySite, Chula Vista
eStudySite, La Mesa
eStudySite, Oceanside
South Jersey Infectious Disease, Somers Point
Lead Sponsor
Melinta Therapeutics, Inc.
INDUSTRY